Global and United States Meropenem Powder Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Meropenem Powder Market
This report focuses on global and United States Meropenem Powder market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Meropenem Powder market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Purity Greater than or Equal to 98% accounting for % of the Meropenem Powder global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Skin Infection was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Meropenem Powder market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Meropenem Powder Scope and Market Size
Meropenem Powder market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Meropenem Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Meropenem Powder market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Purity Greater than or Equal to 98%
    Purity Greater than or Equal to 99%

Segment by Application
    Skin Infection
    Bacterial Meningitis
    Pneumonia
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Pfizer
    AuroMedics
    Sandoz
    Amneal Pharmaceuticals
    Sumitomo Dainippon Pharma
    Ranbaxy Laboratories
    Mylan
    Sagent Pharmaceuticals
    Macleods Pharmaceuticals
    Shenzhen Haibin Pharmaceutical
    Chongqing Tiandi Pharmaceutical
    PKU HealthCare
    United Laboratories
    CSPC Group
    Zhejiang Hisun Pharmaceutical
    Luoxin Pharmaceutical

 1 Study Coverage
    1.1 Meropenem Powder Product Introduction
    1.2 Global Meropenem Powder Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Meropenem Powder Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Meropenem Powder Sales in Volume for the Year 2017-2028
    1.3 United States Meropenem Powder Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Meropenem Powder Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Meropenem Powder Sales in Volume for the Year 2017-2028
    1.4 Meropenem Powder Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Meropenem Powder in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Meropenem Powder Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Meropenem Powder Market Dynamics
        1.5.1 Meropenem Powder Industry Trends
        1.5.2 Meropenem Powder Market Drivers
        1.5.3 Meropenem Powder Market Challenges
        1.5.4 Meropenem Powder Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Meropenem Powder Market Segment by Type
        2.1.1 Purity Greater than or Equal to 98%
        2.1.2 Purity Greater than or Equal to 99%
    2.2 Global Meropenem Powder Market Size by Type
        2.2.1 Global Meropenem Powder Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Meropenem Powder Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Meropenem Powder Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Meropenem Powder Market Size by Type
        2.3.1 United States Meropenem Powder Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Meropenem Powder Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Meropenem Powder Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Meropenem Powder Market Segment by Application
        3.1.1 Skin Infection
        3.1.2 Bacterial Meningitis
        3.1.3 Pneumonia
        3.1.4 Others
    3.2 Global Meropenem Powder Market Size by Application
        3.2.1 Global Meropenem Powder Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Meropenem Powder Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Meropenem Powder Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Meropenem Powder Market Size by Application
        3.3.1 United States Meropenem Powder Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Meropenem Powder Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Meropenem Powder Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Meropenem Powder Competitor Landscape by Company
    4.1 Global Meropenem Powder Market Size by Company
        4.1.1 Top Global Meropenem Powder Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Meropenem Powder Revenue by Manufacturer (2017-2022)
        4.1.3 Global Meropenem Powder Sales by Manufacturer (2017-2022)
        4.1.4 Global Meropenem Powder Price by Manufacturer (2017-2022)
    4.2 Global Meropenem Powder Concentration Ratio (CR)
        4.2.1 Meropenem Powder Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Meropenem Powder in 2021
        4.2.3 Global Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Meropenem Powder Manufacturing Base Distribution, Product Type
        4.3.1 Global Meropenem Powder Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Meropenem Powder Product Type
        4.3.3 Date of International Manufacturers Enter into Meropenem Powder Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Meropenem Powder Market Size by Company
        4.5.1 Top Meropenem Powder Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Meropenem Powder Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Meropenem Powder Sales by Players (2020, 2021 & 2022)

 5 Global Meropenem Powder Market Size by Region
    5.1 Global Meropenem Powder Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Meropenem Powder Market Size in Volume by Region (2017-2028)
        5.2.1 Global Meropenem Powder Sales in Volume by Region: 2017-2022
        5.2.2 Global Meropenem Powder Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Meropenem Powder Market Size in Value by Region (2017-2028)
        5.3.1 Global Meropenem Powder Sales in Value by Region: 2017-2022
        5.3.2 Global Meropenem Powder Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Meropenem Powder Market Size YoY Growth 2017-2028
        6.1.2 North America Meropenem Powder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Meropenem Powder Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Meropenem Powder Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Meropenem Powder Market Size YoY Growth 2017-2028
        6.3.2 Europe Meropenem Powder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Meropenem Powder Market Size YoY Growth 2017-2028
        6.4.2 Latin America Meropenem Powder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Meropenem Powder Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Meropenem Powder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporation Information
        7.1.2 Pfizer Description and Business Overview
        7.1.3 Pfizer Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Pfizer Meropenem Powder Products Offered
        7.1.5 Pfizer Recent Development
    7.2 AuroMedics
        7.2.1 AuroMedics Corporation Information
        7.2.2 AuroMedics Description and Business Overview
        7.2.3 AuroMedics Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 AuroMedics Meropenem Powder Products Offered
        7.2.5 AuroMedics Recent Development
    7.3 Sandoz
        7.3.1 Sandoz Corporation Information
        7.3.2 Sandoz Description and Business Overview
        7.3.3 Sandoz Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sandoz Meropenem Powder Products Offered
        7.3.5 Sandoz Recent Development
    7.4 Amneal Pharmaceuticals
        7.4.1 Amneal Pharmaceuticals Corporation Information
        7.4.2 Amneal Pharmaceuticals Description and Business Overview
        7.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Amneal Pharmaceuticals Meropenem Powder Products Offered
        7.4.5 Amneal Pharmaceuticals Recent Development
    7.5 Sumitomo Dainippon Pharma
        7.5.1 Sumitomo Dainippon Pharma Corporation Information
        7.5.2 Sumitomo Dainippon Pharma Description and Business Overview
        7.5.3 Sumitomo Dainippon Pharma Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Sumitomo Dainippon Pharma Meropenem Powder Products Offered
        7.5.5 Sumitomo Dainippon Pharma Recent Development
    7.6 Ranbaxy Laboratories
        7.6.1 Ranbaxy Laboratories Corporation Information
        7.6.2 Ranbaxy Laboratories Description and Business Overview
        7.6.3 Ranbaxy Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Ranbaxy Laboratories Meropenem Powder Products Offered
        7.6.5 Ranbaxy Laboratories Recent Development
    7.7 Mylan
        7.7.1 Mylan Corporation Information
        7.7.2 Mylan Description and Business Overview
        7.7.3 Mylan Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Mylan Meropenem Powder Products Offered
        7.7.5 Mylan Recent Development
    7.8 Sagent Pharmaceuticals
        7.8.1 Sagent Pharmaceuticals Corporation Information
        7.8.2 Sagent Pharmaceuticals Description and Business Overview
        7.8.3 Sagent Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Sagent Pharmaceuticals Meropenem Powder Products Offered
        7.8.5 Sagent Pharmaceuticals Recent Development
    7.9 Macleods Pharmaceuticals
        7.9.1 Macleods Pharmaceuticals Corporation Information
        7.9.2 Macleods Pharmaceuticals Description and Business Overview
        7.9.3 Macleods Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Macleods Pharmaceuticals Meropenem Powder Products Offered
        7.9.5 Macleods Pharmaceuticals Recent Development
    7.10 Shenzhen Haibin Pharmaceutical
        7.10.1 Shenzhen Haibin Pharmaceutical Corporation Information
        7.10.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
        7.10.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Products Offered
        7.10.5 Shenzhen Haibin Pharmaceutical Recent Development
    7.11 Chongqing Tiandi Pharmaceutical
        7.11.1 Chongqing Tiandi Pharmaceutical Corporation Information
        7.11.2 Chongqing Tiandi Pharmaceutical Description and Business Overview
        7.11.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Products Offered
        7.11.5 Chongqing Tiandi Pharmaceutical Recent Development
    7.12 PKU HealthCare
        7.12.1 PKU HealthCare Corporation Information
        7.12.2 PKU HealthCare Description and Business Overview
        7.12.3 PKU HealthCare Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 PKU HealthCare Products Offered
        7.12.5 PKU HealthCare Recent Development
    7.13 United Laboratories
        7.13.1 United Laboratories Corporation Information
        7.13.2 United Laboratories Description and Business Overview
        7.13.3 United Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 United Laboratories Products Offered
        7.13.5 United Laboratories Recent Development
    7.14 CSPC Group
        7.14.1 CSPC Group Corporation Information
        7.14.2 CSPC Group Description and Business Overview
        7.14.3 CSPC Group Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 CSPC Group Products Offered
        7.14.5 CSPC Group Recent Development
    7.15 Zhejiang Hisun Pharmaceutical
        7.15.1 Zhejiang Hisun Pharmaceutical Corporation Information
        7.15.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
        7.15.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Zhejiang Hisun Pharmaceutical Products Offered
        7.15.5 Zhejiang Hisun Pharmaceutical Recent Development
    7.16 Luoxin Pharmaceutical
        7.16.1 Luoxin Pharmaceutical Corporation Information
        7.16.2 Luoxin Pharmaceutical Description and Business Overview
        7.16.3 Luoxin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Luoxin Pharmaceutical Products Offered
        7.16.5 Luoxin Pharmaceutical Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Meropenem Powder Industry Chain Analysis
    8.2 Meropenem Powder Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Meropenem Powder Distributors
    8.3 Meropenem Powder Production Mode & Process
    8.4 Meropenem Powder Sales and Marketing
        8.4.1 Meropenem Powder Sales Channels
        8.4.2 Meropenem Powder Distributors
    8.5 Meropenem Powder Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Meropenem Powder CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Meropenem Powder Market Trends
    Table 3. Meropenem Powder Market Drivers
    Table 4. Meropenem Powder Market Challenges
    Table 5. Meropenem Powder Market Restraints
    Table 6. Global Meropenem Powder Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Meropenem Powder Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Meropenem Powder Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Meropenem Powder Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Meropenem Powder Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Meropenem Powder Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Meropenem Powder Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Meropenem Powder Sales by Manufacturer, (Ton), 2017-2022
    Table 14. Global Meropenem Powder Sales Share by Manufacturer, 2017-2022
    Table 15. Global Meropenem Powder Price by Manufacturer (2017-2022) & (US$/Kg)
    Table 16. Global Meropenem Powder Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Meropenem Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Powder as of 2021)
    Table 18. Top Players of Meropenem Powder in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Meropenem Powder Product Type
    Table 20. Date of International Manufacturers Enter into Meropenem Powder Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Meropenem Powder Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Meropenem Powder Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Meropenem Powder Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Meropenem Powder Sales by Players, (Ton), 2020, 2021 & 2022
    Table 26. United States Meropenem Powder Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Meropenem Powder Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Meropenem Powder Sales in Volume by Region (2017-2022) & (Ton)
    Table 29. Global Meropenem Powder Sales in Volume Forecast by Region (2023-2028) & (Ton)
    Table 30. Global Meropenem Powder Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Meropenem Powder Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Meropenem Powder Sales in Volume by Country (2017-2028) & (Ton)
    Table 33. North America Meropenem Powder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Meropenem Powder Sales in Volume by Region (2017-2028) & (Ton)
    Table 35. Asia Pacific Meropenem Powder Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Meropenem Powder Sales in Volume by Country (2017-2028) & (Ton)
    Table 37. Europe Meropenem Powder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Meropenem Powder Sales in Volume by Country (2017-2028) & (Ton)
    Table 39. Latin Americaa Meropenem Powder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Meropenem Powder Sales in Volume by Country (2017-2028) & (Ton)
    Table 41. Middle East and Africa Meropenem Powder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 45. Pfizer Meropenem Powder Product
    Table 46. Pfizer Recent Development
    Table 47. AuroMedics Corporation Information
    Table 48. AuroMedics Description and Business Overview
    Table 49. AuroMedics Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 50. AuroMedics Product
    Table 51. AuroMedics Recent Development
    Table 52. Sandoz Corporation Information
    Table 53. Sandoz Description and Business Overview
    Table 54. Sandoz Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 55. Sandoz Product
    Table 56. Sandoz Recent Development
    Table 57. Amneal Pharmaceuticals Corporation Information
    Table 58. Amneal Pharmaceuticals Description and Business Overview
    Table 59. Amneal Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 60. Amneal Pharmaceuticals Product
    Table 61. Amneal Pharmaceuticals Recent Development
    Table 62. Sumitomo Dainippon Pharma Corporation Information
    Table 63. Sumitomo Dainippon Pharma Description and Business Overview
    Table 64. Sumitomo Dainippon Pharma Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 65. Sumitomo Dainippon Pharma Product
    Table 66. Sumitomo Dainippon Pharma Recent Development
    Table 67. Ranbaxy Laboratories Corporation Information
    Table 68. Ranbaxy Laboratories Description and Business Overview
    Table 69. Ranbaxy Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 70. Ranbaxy Laboratories Product
    Table 71. Ranbaxy Laboratories Recent Development
    Table 72. Mylan Corporation Information
    Table 73. Mylan Description and Business Overview
    Table 74. Mylan Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 75. Mylan Product
    Table 76. Mylan Recent Development
    Table 77. Sagent Pharmaceuticals Corporation Information
    Table 78. Sagent Pharmaceuticals Description and Business Overview
    Table 79. Sagent Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 80. Sagent Pharmaceuticals Product
    Table 81. Sagent Pharmaceuticals Recent Development
    Table 82. Macleods Pharmaceuticals Corporation Information
    Table 83. Macleods Pharmaceuticals Description and Business Overview
    Table 84. Macleods Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 85. Macleods Pharmaceuticals Product
    Table 86. Macleods Pharmaceuticals Recent Development
    Table 87. Shenzhen Haibin Pharmaceutical Corporation Information
    Table 88. Shenzhen Haibin Pharmaceutical Description and Business Overview
    Table 89. Shenzhen Haibin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 90. Shenzhen Haibin Pharmaceutical Product
    Table 91. Shenzhen Haibin Pharmaceutical Recent Development
    Table 92. Chongqing Tiandi Pharmaceutical Corporation Information
    Table 93. Chongqing Tiandi Pharmaceutical Description and Business Overview
    Table 94. Chongqing Tiandi Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 95. Chongqing Tiandi Pharmaceutical Product
    Table 96. Chongqing Tiandi Pharmaceutical Recent Development
    Table 97. PKU HealthCare Corporation Information
    Table 98. PKU HealthCare Description and Business Overview
    Table 99. PKU HealthCare Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 100. PKU HealthCare Product
    Table 101. PKU HealthCare Recent Development
    Table 102. United Laboratories Corporation Information
    Table 103. United Laboratories Description and Business Overview
    Table 104. United Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 105. United Laboratories Product
    Table 106. United Laboratories Recent Development
    Table 107. CSPC Group Corporation Information
    Table 108. CSPC Group Description and Business Overview
    Table 109. CSPC Group Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 110. CSPC Group Product
    Table 111. CSPC Group Recent Development
    Table 112. Zhejiang Hisun Pharmaceutical Corporation Information
    Table 113. Zhejiang Hisun Pharmaceutical Description and Business Overview
    Table 114. Zhejiang Hisun Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 115. Zhejiang Hisun Pharmaceutical Product
    Table 116. Zhejiang Hisun Pharmaceutical Recent Development
    Table 117. Luoxin Pharmaceutical Corporation Information
    Table 118. Luoxin Pharmaceutical Description and Business Overview
    Table 119. Luoxin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 120. Luoxin Pharmaceutical Product
    Table 121. Luoxin Pharmaceutical Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Meropenem Powder Customers List
    Table 125. Meropenem Powder Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meropenem Powder Product Picture
    Figure 2. Global Meropenem Powder Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Meropenem Powder Market Size 2017-2028 (US$ Million)
    Figure 4. Global Meropenem Powder Sales 2017-2028 (Ton)
    Figure 5. United States Meropenem Powder Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Meropenem Powder Market Size 2017-2028 (US$ Million)
    Figure 7. United States Meropenem Powder Sales 2017-2028 (Ton)
    Figure 8. United States Meropenem Powder Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Meropenem Powder Market Share in Global, in Volume (Ton) 2017-2028
    Figure 10. Meropenem Powder Report Years Considered
    Figure 11. Product Picture of Purity Greater than or Equal to 98%
    Figure 12. Product Picture of Purity Greater than or Equal to 99%
    Figure 13. Global Meropenem Powder Market Share by Type in 2022 & 2028
    Figure 14. Global Meropenem Powder Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Meropenem Powder Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Meropenem Powder Sales by Type (2017-2028) & (Ton)
    Figure 17. Global Meropenem Powder Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Meropenem Powder Price by Type (2017-2028) & (US$/Kg)
    Figure 19. United States Meropenem Powder Market Share by Type in 2022 & 2028
    Figure 20. United States Meropenem Powder Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Meropenem Powder Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Meropenem Powder Sales by Type (2017-2028) & (Ton)
    Figure 23. United States Meropenem Powder Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Meropenem Powder Price by Type (2017-2028) & (US$/Kg)
    Figure 25. Product Picture of Skin Infection
    Figure 26. Product Picture of Bacterial Meningitis
    Figure 27. Product Picture of Pneumonia
    Figure 28. Product Picture of Others
    Figure 29. Global Meropenem Powder Market Share by Application in 2022 & 2028
    Figure 30. Global Meropenem Powder Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Meropenem Powder Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Meropenem Powder Sales by Application (2017-2028) & (Ton)
    Figure 33. Global Meropenem Powder Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Meropenem Powder Price by Application (2017-2028) & (US$/Kg)
    Figure 35. United States Meropenem Powder Market Share by Application in 2022 & 2028
    Figure 36. United States Meropenem Powder Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Meropenem Powder Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Meropenem Powder Sales by Application (2017-2028) & (Ton)
    Figure 39. United States Meropenem Powder Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Meropenem Powder Price by Application (2017-2028) & (US$/Kg)
    Figure 41. North America Meropenem Powder Sales in Volume Growth Rate 2017-2028 (Ton)
    Figure 42. North America Meropenem Powder Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. United States Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Meropenem Powder Sales in Volume Growth Rate 2017-2028 (Ton)
    Figure 46. Europe Meropenem Powder Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Meropenem Powder Sales in Volume Growth Rate 2017-2028 (Ton)
    Figure 53. Asia-Pacific Meropenem Powder Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Meropenem Powder Sales in Volume Growth Rate 2017-2028 (Ton)
    Figure 64. Latin America Meropenem Powder Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Meropenem Powder Sales in Volume Growth Rate 2017-2028 (Ton)
    Figure 69. Middle East & Africa Meropenem Powder Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Meropenem Powder Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Meropenem Powder Value Chain
    Figure 74. Meropenem Powder Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Market Analysis and Insights: Global and United States Meropenem Powder Market
This report focuses on global and United States Meropenem Powder market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Meropenem Powder market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Purity Greater than or Equal to 98% accounting for % of the Meropenem Powder global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Skin Infection was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Meropenem Powder market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Meropenem Powder Scope and Market Size
Meropenem Powder market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Meropenem Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Meropenem Powder market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Purity Greater than or Equal to 98%
    Purity Greater than or Equal to 99%

Segment by Application
    Skin Infection
    Bacterial Meningitis
    Pneumonia
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Pfizer
    AuroMedics
    Sandoz
    Amneal Pharmaceuticals
    Sumitomo Dainippon Pharma
    Ranbaxy Laboratories
    Mylan
    Sagent Pharmaceuticals
    Macleods Pharmaceuticals
    Shenzhen Haibin Pharmaceutical
    Chongqing Tiandi Pharmaceutical
    PKU HealthCare
    United Laboratories
    CSPC Group
    Zhejiang Hisun Pharmaceutical
    Luoxin Pharmaceutical